Powered by Smartsupp Uncategorized | True Meds

Category Archives: Uncategorized

Gallic Acid: The Antioxidant Powerhouse with Anticancer and Anti-Inflammatory Benefits

Gallic acid, a naturally occurring polyphenol found in plants, fruits, and teas, offers a broad spectrum of health benefits supported by modern research. Known for its antioxidant, anti-inflammatory, antimicrobial, and anticancer properties, gallic acid is gaining recognition as a promising natural compound in preventive health and functional nutrition. It works through mechanisms that include free […]

Decoding Cancer Pathways: The Multifaceted Role of PKC Isozymes in Tumor Progression and Therapy

Protein Kinase C (PKC) isozymes are a diverse family of serine/threonine kinases that play critical roles in regulating cellular signaling pathways. Their isoform-specific functions in processes such as proliferation, apoptosis, migration, and differentiation make them central to the molecular mechanisms of cancer. This blog explores the classification of PKC isozymes and their context-dependent involvement in […]

Decoding DNA Methylation: What We Now Know About Epigenetics and Development

DNA methylation is a cornerstone of epigenetic regulation, influencing gene expression, genomic stability, and developmental programming. While early models suggested widespread and dynamic methylation changes across the genome, recent high-resolution analyses have challenged this view. Drawing on insights from Edwards et al. (2017), this blog post revisits the landscape of DNA methylation, revealing that functionally […]

Enlicitide in Hyperlipidemia: Mechanism, Clinical Evidence, and Future Outlook

Enlicitide in Hyperlipidemia:, characterized by elevated LDL-C levels, is a major global health concern and a key contributor to atherosclerotic cardiovascular disease (ASCVD). While lifestyle modifications are foundational in managing lipid levels, pharmacologic intervention is often necessary for high-risk individuals. Enlicitide, a novel oral PCSK9 inhibitor, offers a promising therapeutic option by inhibiting PCSK9 and […]

Perphenazine: Uses, Side Effects, and What You Need to Know

Perphenazine: Uses, Side Effects

Perphenazine is a typical antipsychotic medication used primarily to treat schizophrenia and severe nausea or vomiting. It functions by blocking dopamine receptors in the brain, helping reduce psychotic symptoms. While effective, it may cause side effects such as extrapyramidal symptoms, sedation, and cardiovascular risks. Proper dosage, careful monitoring, and medical supervision are crucial for safe […]

Ceramides: The Secret to Stronger, Healthier Skin Barrier

Ceramides are essential lipid molecules naturally found in the skin, playing a critical role in maintaining hydration, protecting the barrier function, and supporting overall skin health. This article explores what ceramides are, their biological structure, and how they function within the epidermis. It outlines the benefits of ceramides for various skin types, especially those prone […]

Targeting BTK: The Science Behind a Game-Changer in Cancer and Autoimmune Therapy

Bruton’s tyrosine kinase (BTK) has emerged as a central regulator of immune signaling, originally linked to X-linked agammaglobulinemia and now a major therapeutic target across oncology, autoimmunity, and infectious diseases. This blog explores BTK’s pivotal role in B-cell receptor signaling and its expanding influence in T cells, macrophages, and inflammatory cascades. We highlight the clinical […]

The Evolution of Bcr-Abl Inhibitors: From Imatinib to Next-Gen Therapies for CML and Beyond

The advent of Bcr-Abl inhibitors has revolutionized the treatment landscape of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). This blog post explores the historical development and structural evolution of these targeted therapies, beginning with imatinib, the first tyrosine kinase inhibitor (TKI) designed to selectively block the Bcr-Abl fusion protein. As […]

Analysis of the mechanism of action of ADC drugs

Antibody-Drug Conjugates (ADCs) are a class of targeted cancer therapies combining monoclonal antibodies with cytotoxic drugs via stable linkers. The antibody component selectively binds to tumor-specific antigens, enabling the delivery of highly potent toxins directly to cancer cells. Once internalized, the linker is cleaved (chemically or enzymatically), releasing the cytotoxic agent that induces apoptosis. Some […]

Targeting Focal Adhesion Kinase in Cancer: Advances in Inhibitors and PROTAC-Based Degraders

Focal Adhesion Kinase (FAK) is a non-receptor tyrosine kinase with dual roles as a signaling enzyme and scaffolding protein, contributing to cancer development, metastasis, and therapy resistance. Although several FAK inhibitors have entered clinical trials, they primarily target kinase activity and fail to eliminate scaffolding functions. Proteolysis-targeting chimeras (PROTACs) offer a novel approach by degrading […]